Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 162

1.

Impact of Untimely Access to Formal Care on Costs and Quality of Life in Community Dwelling People with Dementia.

Janssen N, Handels RL, Sköldunger A, Woods B, Jelley H, Tudor Edwards R, Orrell M, Selbæk G, Røsvik J, Gonçalves-Pereira M, Marques MJ, Zanetti O, Portolani E, Irving K, Hopper L, Meyer G, Bieber A, Stephan A, Kerpershoek L, Wolfs CAG, de Vugt ME, Verhey FRJ, Wimo A.

J Alzheimers Dis. 2018 Oct 29. doi: 10.3233/JAD-180531. [Epub ahead of print]

PMID:
30400096
2.

A comparison of self and proxy quality of life ratings for people with dementia and their carers: a European prospective cohort study.

O'Shea E, Hopper L, Marques M, Gonçalves-Pereira M, Woods B, Jelley H, Verhey F, Kerpershoek L, Wolfs C, de Vugt M, Stephan A, Bieber A, Meyer G, Wimo A, Michelet M, Selbaek G, Portolani E, Zanetti O, Irving K; Actifcare Consortium.

Aging Ment Health. 2018 Nov 1:1-9. doi: 10.1080/13607863.2018.1517727. [Epub ahead of print]

PMID:
30381955
3.

Quality of Life, Care Resource Use, and Costs of Dementia in 8 European Countries in a Cross-Sectional Cohort of the Actifcare Study.

Handels RLH, Sköldunger A, Bieber A, Edwards RT, Gonçalves-Pereira M, Hopper L, Irving K, Jelley H, Kerpershoek L, Marques MJ, Meyer G, Michelet M, Portolani E, Rsvik J, Selbaek G, Stephan A, de Vugt M, Wolfs C, Woods B, Zanetti O, Verhey F, Wimo A; and Actifcare consortium.

J Alzheimers Dis. 2018 Oct 25. doi: 10.3233/JAD-180275. [Epub ahead of print]

PMID:
30372674
4.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

5.

An 87-year-old female with interest in music, botany, trekking stories, politics and … junk.

Reedy SS, Spassini W, Berruti N, Stefano B, Polotti R, Zanetti O.

Aging Clin Exp Res. 2018 Jul 13. doi: 10.1007/s40520-018-0996-8. [Epub ahead of print] No abstract available.

PMID:
30006763
6.

Barriers and facilitators to the access to and use of formal dementia care: findings of a focus group study with people with dementia, informal carers and health and social care professionals in eight European countries.

Stephan A, Bieber A, Hopper L, Joyce R, Irving K, Zanetti O, Portolani E, Kerpershoek L, Verhey F, de Vugt M, Wolfs C, Eriksen S, Røsvik J, Marques MJ, Gonçalves-Pereira M, Sjölund BM, Jelley H, Woods B, Meyer G; Actifcare Consortium.

BMC Geriatr. 2018 Jun 4;18(1):131. doi: 10.1186/s12877-018-0816-1.

7.

[Managing insomnia in the elderly patient: from pharmacology to subthreshold depression].

Scaglione F, Vampini C, Parrino L, Zanetti O.

Riv Psichiatr. 2018 Jan-Feb;53(1):5-17. doi: 10.1708/2866.28919. Review. Italian.

PMID:
29493650
8.

The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort.

Fostinelli S, Ciani M, Zanardini R, Zanetti O, Binetti G, Ghidoni R, Benussi L.

J Alzheimers Dis. 2018;61(2):753-760. doi: 10.3233/JAD-170661.

PMID:
29226869
9.

Needs and quality of life of people with middle-stage dementia and their family carers from the European Actifcare study. When informal care alone may not suffice.

Kerpershoek L, de Vugt M, Wolfs C, Woods B, Jelley H, Orrell M, Stephan A, Bieber A, Meyer G, Selbaek G, Handels R, Wimo A, Hopper L, Irving K, Marques M, Gonçalves-Pereira M, Portolani E, Zanetti O, Verhey F; Actifcare Consortium.

Aging Ment Health. 2018 Jul;22(7):897-902. doi: 10.1080/13607863.2017.1390732. Epub 2017 Oct 25.

PMID:
29068697
10.

Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study.

Tremolizzo L, Bianchi E, Susani E, Pupillo E, Messina P, Aliprandi A, Salmaggi A, Cosseddu M, Pilotto A, Borroni B, Padovani A, Bonomini C, Zanetti O, Appollonio I, Beghi E, Ferrarese C.

J Alzheimers Dis. 2017;60(2):335-340. doi: 10.3233/JAD-170260.

PMID:
28946566
11.

Perspectives of policy and political decision makers on access to formal dementia care: expert interviews in eight European countries.

Broda A, Bieber A, Meyer G, Hopper L, Joyce R, Irving K, Zanetti O, Portolani E, Kerpershoek L, Verhey F, Vugt M, Wolfs C, Eriksen S, Røsvik J, Marques MJ, Gonçalves-Pereira M, Sjölund BM, Woods B, Jelley H, Orrell M, Stephan A; ActifCare Consortium.

BMC Health Serv Res. 2017 Aug 3;17(1):518. doi: 10.1186/s12913-017-2456-0.

12.

Access to community care for people with dementia and their informal carers : Case vignettes for a European comparison of structures and common pathways to formal care.

Bieber A, Stephan A, Verbeek H, Verhey F, Kerpershoek L, Wolfs C, de Vugt M, Woods RT, Røsvik J, Selbaek G, Sjölund BM, Wimo A, Hopper L, Irving K, Marques MJ, Gonçalves-Pereira M, Portolani E, Zanetti O, Meyer G.

Z Gerontol Geriatr. 2018 Jul;51(5):530-536. doi: 10.1007/s00391-017-1266-7. Epub 2017 Jun 14.

PMID:
28616816
13.

Caregiver profiles in dementia related to quality of life, depression and perseverance time in the European Actifcare study: the importance of social health.

Janssen EP, de Vugt M, Köhler S, Wolfs C, Kerpershoek L, Handels RL, Orrell M, Woods B, Jelley H, Stephan A, Bieber A, Meyer G, Engedal K, Selbaek G, Wimo A, Irving K, Hopper L, Gonçalves-Pereira M, Portolani E, Zanetti O, Verhey FR.

Aging Ment Health. 2017 Jan;21(1):49-57. doi: 10.1080/13607863.2016.1255716. Epub 2016 Nov 21.

PMID:
27869480
14.

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study.

Boccardi M, Altomare D, Ferrari C, Festari C, Guerra UP, Paghera B, Pizzocaro C, Lussignoli G, Geroldi C, Zanetti O, Cotelli MS, Turla M, Borroni B, Rozzini L, Mirabile D, Defanti C, Gennuso M, Prelle A, Gentile S, Morandi A, Vollaro S, Volta GD, Bianchetti A, Conti MZ, Cappuccio M, Carbone P, Bellandi D, Abruzzi L, Bettoni L, Villani D, Raimondi MC, Lanari A, Ciccone A, Facchi E, Di Fazio I, Rozzini R, Boffelli S, Manzoni L, Salvi GP, Cavaliere S, Belotti G, Avanzi S, Pasqualetti P, Muscio C, Padovani A, Frisoni GB; Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Working Group.

JAMA Neurol. 2016 Dec 1;73(12):1417-1424. doi: 10.1001/jamaneurol.2016.3751.

PMID:
27802513
15.

Erratum to: Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study.

Kerpershoek L, de Vugt M, Wolfs C, Jelley H, Orrell M, Woods B, Stephan A, Bieber A, Meyer G, Engedal K, Selbaek G, Handels R, Wimo A, Hopper L, Irving K, Marques M, Gonçalves-Pereira M, Portolani E, Zanetti O, Verhey F; Actifcare Consortium.

BMC Health Serv Res. 2016 Oct 28;16(1):620. No abstract available.

16.

Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.

Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB; INDIA-FBP Group.

Neurobiol Aging. 2017 Jan;49:60-68. doi: 10.1016/j.neurobiolaging.2016.08.019. Epub 2016 Aug 31.

PMID:
27776263
17.

Access to timely formal dementia care in Europe: protocol of the Actifcare (ACcess to Timely Formal Care) study.

Kerpershoek L, de Vugt M, Wolfs C, Jelley H, Orrell M, Woods B, Stephan A, Bieber A, Meyer G, Engedal K, Selbaek G, Handels R, Wimo A, Hopper L, Irving K, Marques M, Gonçalves-Pereira M, Portolani E, Zanetti O, Verhey F; Actifcare Consortium.

BMC Health Serv Res. 2016 Aug 23;16(1):423. doi: 10.1186/s12913-016-1672-3. Erratum in: BMC Health Serv Res. 2016 Oct 28;16(1):620.

18.

Grey Matter Density Predicts the Improvement of Naming Abilities After tDCS Intervention in Agrammatic Variant of Primary Progressive Aphasia.

Cotelli M, Manenti R, Paternicò D, Cosseddu M, Brambilla M, Petesi M, Premi E, Gasparotti R, Zanetti O, Padovani A, Borroni B.

Brain Topogr. 2016 Sep;29(5):738-51. doi: 10.1007/s10548-016-0494-2. Epub 2016 May 19.

PMID:
27194245
19.

Erratum to: Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Squitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, Mariani S, Rongioletti M, Zanetti O, Congiu C, Rossini PM, Bonvicini C.

Mol Neurobiol. 2017 Jan;54(1):682-683. doi: 10.1007/s12035-016-9734-4. No abstract available.

PMID:
26819212
20.

Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Squitti R, Ventriglia M, Gennarelli M, Colabufo NA, El Idrissi IG, Bucossi S, Mariani S, Rongioletti M, Zanetti O, Congiu C, Rossini PM, Bonvicini C.

Mol Neurobiol. 2017 Jan;54(1):671-681. doi: 10.1007/s12035-015-9664-6. Epub 2016 Jan 12. Erratum in: Mol Neurobiol. 2017 Jan;54(1):682-683.

PMID:
26758278

Supplemental Content

Loading ...
Support Center